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Abstract: Artemisinin (ART) is a sesquiterpene lactone and a popular malaria drug used in many
parts of the world. Artesunate (ARTS) is a semi-synthetic derivative of ART with improved pharmacokinetic properties. However, the half-life of ARTS is less than an hour in vivo. The analysis of this
drug in vitro in different solvent systems using LC-MS/TOF showed a solvent-driven breakdown.
ARTS breakdown formed several derivatives, including dihydroartemisinin (DHA), artemether
(ARTM) and DHA-dimer among others, at different rates in different solvent composition systems.
The change in temperature from room temperature to physiological temperature (37 ◦ C) was found
to enhance the rate of the ARTS breakdown. In methanol, ARTS mainly formed ARTM with a
chromatographic peak decrease of about 3.13%, while methanol and water (90:10) v/v mainly gave
rise to DHA and ARTM with about an 80% chromatographic peak decrease. On the other hand,
ARTS in methanol and ammonium acetate (85:15) v/v formed DHA, ARTM, DHA-dimer and other
reaction peaks with about a 97% peak decrease and the formation of an orange solution pointing to
a molecular re-arrangement reaction. These results have an important bearing on research on the
analysis of artemisinin drugs conducted on these common solvents.
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1. Introduction
ART derivatives possess a potent antimalarial activity. They are very active against
all Plasmodium species and the asexual blood stage of malaria parasites [1,2]. ART is
a sesquiterpene lactone derived from the Chinese medicinal plant qinghao, also known
as Artemisia annua or sweet wormwood [3]. It is a 1,2,4-trioxane ring system with an
internal peroxide bridge [4]. Synthetic and semi-synthetic derivatives of ART include
ARTS, which mainly improves the pharmacokinetic limitations of ART. These limitations
in ART include poor solubility, low bioavailability and a short half-life [5]. DHA was
one of the first semi-synthetic functional derivatives of ART [6]. Other first-generation
semi-synthetic derivatives included arteeter and ARTM, which are lipid-soluble, while
ARTS is water-soluble [7].
The natural 1,2,4-trioxane pharmacophore in all artemisinins is responsible for the
antimalarial activity [8,9]. The dosage is prescribed as a combination therapy to manage
infection and to reduce resistance against the ARTs [10,11]. Although the mechanisms of
action of these drugs are not well understood, the endo-peroxide bridge is suggested to
play a key role in the overall mechanism of action [12,13]. Recent reports suggest that
artemisinins possess anticancer properties [14,15]. Cancer drugs are usually toxic to both
cancerous cells as well as normal cells. Artemisinins present no significant cytotoxicity to
normal cells according to thousands of studies so far from thousands of malaria patients [16].
They were found to be effective against several cancers including throat cancer [17], ovarian
cancer [18], breast cancer [19], colon cancer [20] and prostate cancer [21], among other
cancer types [22]. In general, ART-derived monomeric molecules in the micro-molar range
showed cytotoxicity to cancer cells, with the IC50 values of ART-dimers in cancer cells
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other cancer types [22]. In general, ART-derived monomeric molecules in the micro-molar
range showed cytotoxicity to cancer cells, with the IC50 values of ART-dimers in cancer
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for conjugation with other drugs. Despite being water-soluble, ARTS has a low stability in
in neutral or acidic pH. Sodium ARTS is known to convert into biologically active metabneutral or acidic pH. Sodium ARTS is known to convert into biologically active metabolite
olite DHA in vivo [26]. Other research reports that after absorption, ARTS rapidly conDHA in vivo [26]. Other research reports that after absorption, ARTS rapidly converts
verts to DHA and that DHA is the form that is responsible for antimalarial activity [27,28].
to DHA and that DHA is the form that is responsible for antimalarial activity [27,28]. In
In other research, the onset of hydrolysis of ARTS into DHA was observed 25 min after
other research, the onset of hydrolysis of ARTS into DHA was observed 25 min after an
an intravenous administration [27]. A linear decomposition of ARTS was observed, with
intravenous administration [27]. A linear decomposition of ARTS was observed, with
only about 31% and 18% of the drug remaining after 18 h of reaction, while the parent
only about 31% and 18% of the drug remaining after 18 h of reaction, while the parent
compound ARTS and the rest were converted into DHA and other products [29]. The rate
compound ARTS and the rest were converted into DHA and other products [29]. The
of decomposition can be affected by physical parameters such as the temperature and solrate of decomposition can be affected by physical parameters such as the temperature and
vent composition.
solvent composition.

Figure 1. Chemical structure of ARTS.
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garding the mobile phases used in relation to the number and size of chromatographic
signals generated.
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2. Materials and Methods
2.1. Chemicals and Reagents
ARTS was purchased from Tokyo Chemical Company (TCI). LC-MS-grade methanol,
ammonium acetate, acetonitrile and water were purchased from VWR. Other chemicals
used for instrument calibration include ESI-L tuning mix and mass reference solutions
(ammonium trifluoroacetate, purine, HP-0921), all LC-MS-grade from Agilent Technologies,
Santa Clara, CA, USA.
2.2. Chromatographic Procedure
The LC-MS analysis was carried out using an Agilent 6230 series LC-MS/TOF unit. The
separation of reaction products was carried out using Agilent Technologies, ZORBAX Eclipse
Plus C-18 RRHD column (2.1 × 50 mm) with 1.8 µm diameter stationary phase particles. The
mobile phase consisted of methanol and water containing 0.1% formic acid (v/v) 70:30. The
chromatographic runs were performed under isocratic conditions at a flow rate of 0.250 mL/min.
Every end of the run was followed by a post-run step that included flushing the column with
the mobile phase repeatedly. The column temperature was set to 25 ◦ C.
2.3. Mass Spectrometer Procedure
The mass spectrometry for the LC/MS was the TOF 6230 series set to Dual AJS ESI
in positive ion mode. The settings of the mass spectrometer were as follows: scan mode
(standard), range (200–3000) m/z, threshold (200), nebulizer gas (40.0 psi) and dry gas
(8.0 L/min), and dry temperature (325 ◦ C). The compound stability and trap drive level
were set to 100%. The MS/MS fragmentation amp was set to 175 V and the skimmer cone
to 65 V. The instrument mode was set to high resolution for tuning and calibration.
2.4. Sample Preparation
Several ARTS samples in 5 mL volumetric flasks were dissolved in different solvent compositions including (i) methanol 100%, (ii) methanol with water, 90:10, and
(iii) 20 mM ammonium acetate buffer with methanol, 15:85 v/v. The concentration of
ARTS in the solutions was maintained at 1.04 × 10−2 M. For the analysis, 1 mL of the
sample mixtures was drawn, filtered, and transferred into individual vials using syringe
filters. A comparison was made for solution mixtures left at room temperature versus those
incubated at 37 ◦ C. Sample mixtures were incubated at 37 ◦ C at different lengths of time
before analysis.
Chromatographic procedures were adjusted to optimize the separation of the elution products. Various mobile phase compositions, flow rates and injection volumes were investigated in
order to effectively separate the samples. An isocratic solvent containing a mixture of methanol
and water was used as the mobile phase for the LC-MS method. After several trials, 70:30 v/v
methanol/water with 0.1% formic acid showed an optimized elution of the reaction products.
In this experiment, the incubation temperature was set to 37 ◦ C, and the column temperature
was maintained at 25 ◦ C, which was about room temperature. After the optimization of the
reaction conditions, each sample was run three times.
3. Results
3.1. ARTS in Methanol
The reaction of ARTS with methanol was monitored by obtaining chromatograms of
the ARTS sample dissolved in methanol and then incubated at room temperature and at
37 ◦ C. Figure 2a shows the LC-MS chromatogram obtained. The sample was first analyzed
immediately after mixing (at room temperature, ~25 ◦ C) and then analyzed again each day
for twenty-one days at 37 ◦ C. On the first day, only one chromatogram peak for ARTS was
obtained at 2.1 min retention time. Upon incubating the mixture at 37 ◦ C, other reaction
product peaks appeared at about 0.9, 1.2, 1.6, 1.9, 2.8, 3.1, 3.4 and 6.0 min. These new
chromatographic reaction product peaks grew with the time of incubation at 37 ◦ C. There
was no further increase of chromatographic peaks after 21 days of continuous incubation
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shows the identification of mass fragments of ARTS reaction products in methanol.
3.2. ARTS in Methanol and Water
The stability of ARTS in methanol/water, 90:10 (v/v), was monitored by collecting
chromatograms of the sample at room temperature and at 37 ◦ C. The sample was immediately analyzed after dissolving in the solvent and then again, each day for twenty-one days.
Figure 3A–C show the obtained chromatograms. On the first day, only one chromatogram peak
for ARTS was obtained at about 2.1 min. Other reaction product peaks appeared at about 0.5,
1.0, 1.6, 1.9, 2.8, 3.2, 3.5 and 6.0 mins upon incubation at 37 ◦ C. These new chromatographic
product peaks grew with the time of incubation at 37 ◦ C. There were no changes in the chro-
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matographic peaks after 21 days of continuous monitoring. Further analysis of these reaction
products followed, using mass spectra. Figure 3D,E show the growth graph of the reaction
peaks. Figure S2 shows the mass spectra of the ARTS reaction peaks.
Table 1. Retention time and fragmentation patterns of ARTS reaction products in methanol.
Retention Time

Main Fragments (m/z)

0.9

407

1.2

407, 791

1.6

221, 307

1.9

261, 307, and 591

2.8

261, 267, 285, 307, 321, 329, 341, 385, and 591

3.1

221, 267, 275, 321, 329, 421, 458, and 619

3.4

221, 249, 267, 285, 289, 311, 329, 341, and 385
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The ARTS peak at 2.1 min continuously decreased, while the DHA peak at 1.9 min
and the ARTM peak at 6.0 min continuously grew. The parent peak of ARTS decreased to
about 80% in 21 days. As compared to ARTS, the percentage increases of the DHA, ARTM
and DHA dimers were 97%, 100% and 15%, respectively. The DHA increase was almost
by the same margin as the reduction of ARTS. Although the initial concentration of ARTS
was high, as shown on the plateau region of the detector, it was clear that it led to the
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The ARTS peak at 2.1 min continuously decreased, while the DHA peak at 1.9 min
and the ARTM peak at 6.0 min continuously grew. The parent peak of ARTS decreased
to about 80% in 21 days. As compared to ARTS, the percentage increases of the DHA,
ARTM and DHA dimers were 97%, 100% and 15%, respectively. The DHA increase was
almost by the same margin as the reduction of ARTS. Although the initial concentration
of ARTS was high, as shown on the plateau region of the detector, it was clear that it led
to the formation of other product chromatographic peaks. In this solvent system, DHA
and ARTM plateaued after 15 and 17 days, respectively (Figure 3D,E). The decline of the
chromatographic peak of ARTS was much slower after 20 days.
The mass spectra of the reaction products corresponding to Figure 3A,B are given in
Figure S2. The major fragment ions include [M+Na]+ , [M+K]+ and [2M+Na]+ , corresponding to m/z of 407, 423 and 791, respectively. The new product chromatographic peaks
appearing between 0.5 and 6.0 min are shown in Table 2. Table S2 shows the identification
of mass fragments of ARTS reaction products in methanol/water.
Table 2. Retention time and fragmentation patterns of ARTS reaction products in methanol: water.
Retention Time

Main Fragments (m/z)

0.5

203, 217, 252, 261, 275, and 305

1.0

203, 217, 221, 261, 293, 305, and 321

1.6

203, 217, 221, and 307

1.9

221, 249, 261, 267, 307, 323, and 591

2.8

203, 217, 221, 249, 261, 267, 307, 323, and 591

3.2

203, 217, 221, 267, 321, 421, and 619

3.5

203, 217, 221, 249, 261, 289, 305, 311, and 351

6.0

221, 249, 267, 275, 321, 337, and 619

3.3. ARTS in Ammonium Acetate and Methanol
The stability of ARTS in 20 mM ammonium acetate: methanol (15:85) v/v at room temperature and at 37 ◦ C was compared using chromatograms collected at different times. The
obtained chromatograms are in Figure 4A. The Figure 4A insert shows the chromatograms
between 1.8 and 2.4 min. There was a notable increase of the product peak and decrease
of the reactant peak. On the first day, one chromatogram peak for ARTS occurred at
2.1 min retention time. Upon continuous incubation at 37 ◦ C, other reaction product peaks
appeared. The main peaks showed up at the following retention times: 0.5, 0.7, 0.8, 0.9,
1.2, 1.3, 1.9, 2.8 and 6.0 mins. The completion of the reaction was observed at day 21 of the
continuous incubation at 37 ◦ C, which was indicated by the reduction of the ARTS peak
and the color change of the sample from clear to orange. Further analysis of these reaction
products followed, using mass spectra. Figure 4B shows peaks’ growth as a function time
in days for all of the significant chromatographic peaks. Figure S3 shows the mass spectra
of the ARTS reaction peaks.
In this solvent system, we find some similar peaks but with different growth rates.
ARTS showed up at its usual retention time at 2.1 min, and the peak intensity decreased,
while the DHA peak at 1.9 min and ARTM peak at 6.0 min increased. The main compound
formed in this reaction was DHA. A decrease of 97% of ARTS and an increase of about
the same amount of DHA show the conversion of ARTS to DHA in this solvent system.
When compared to ARTS, the percentage increase of ARTM was about 17.17%, while the
percentage increase of the peak of the DHA dimer was 32.32%. Based on the mass spectra
obtained, the peak at 2.8 min was assigned to the DHA dimer.

Separations 2022, 9, 218

7 of 11

Separations 2022, 9, x FOR PEER REVIEW

8 of 12

(B)
Figure
(A) Daily
chromatograms
ARTSreaction
reaction in
acetate:
methanol
Figure
4. (A)4. Daily
TICTIC
chromatograms
ofofARTS
in 20
20mM
mMammonium
ammonium
acetate:
methanol
◦ C. Peak
obtained
at room
temperature
37 (B)
(B) Peak
intensity
a function
of time
(days)
obtained
at room
temperature
andand
at 37at°C.
intensity
as aasfunction
of time
(days)
forfor
chromatographic
peaks representing
DHA, DHA,
ARTS,ARTS,
ARTM
and and
DHA
dimers.
chromatographic
peaks representing
ARTM
DHA
dimers.

Thesolvent
introduction
of ammonia
the solvent
system
resulted
in the different
formation growth
of a colored
In this
system,
we findinsome
similar
peaks
but with
rates.
compound. The mechanism behind this was speculated to involve nitrogen from ammonia.
ARTS showed up at its usual retention time at 2.1 min, and the peak intensity decreased,
This ARTS caused a breakdown of the peroxide bond resulting in a more enhanced conjugated
whilemolecule
the DHA
peak
at 1.9
andcompound.
ARTM peak
atreaction
6.0 minwas
increased.
main
compound
and,
hence,
themin
colored
This
observedThe
to be
a function
of
formed
injudging
this reaction
DHA.
A decrease ofproduct
97% ofpeaks.
ARTS and an increase of about
time,
from thewas
growing
chromatographic
the same The
amount
DHAofshow
the conversion
ARTS to DHA
in this4asolvent
system.
mass of
spectra
the reaction
products of
corresponding
to Figure
are given
in
+
When
compared
to ARTS
ARTS,molecular
the percentage
increase
ARTM
about
17.17%,
while+the
Figure
S3. The
ion is 384.
The of
other
ions was
include
[M+Na]
, [M+K]
+ , corresponding to m/z of 407, 423 and 791, respectively. The new product
and [2M+Na]
percentage
increase
of the peak of the DHA dimer was 32.32%. Based on the mass spectra
chromatographic
appearing
betweento0.5
and
6.0 min
are shown in Table 3. Table S3
obtained,
the peak atpeaks
2.8 min
was assigned
the
DHA
dimer.
shows
the
identification
of
mass
fragments
of
ARTS
reaction
products
mMformation
ammoniumof a
The introduction of ammonia in the solvent system resultedinin20the
acetate: methanol.
colored compound. The mechanism behind this was speculated to involve nitrogen from
ammonia. This ARTS caused a breakdown of the peroxide bond resulting in a more enhanced conjugated molecule and, hence, the colored compound. This reaction was observed to be a function of time, judging from the growing chromatographic product peaks.
The mass spectra of the reaction products corresponding to Figure 4a are given in
Figure S3. The ARTS molecular ion is 384. The other ions include [M+Na]+, [M+ K]+ and
[2M+Na]+, corresponding to m/z of 407, 423 and 791, respectively. The new product chro-
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Table 3. Retention time and fragmentation patterns of ARTS reaction products in 20 mM ammonium
acetate: methanol.
Retention Time

Main Fragments (m/z)

0.5

218, 230, 232, 245, 248, 260, 276, and 308

0.7

232, 236, and 265

0.8

206, 262, 307, and 329

0.9

248, 267, 291, 307, 329, 341, 369, 385, 407, and 467.

1.3

214, 246, and 307

1.9

221, 261, 307, 591, and 573

2.8

261, 307, and 591

6.0

221, 275, 321, and 619

4. Discussion
Mobile phase buffers and solvents are not supposed to participate in any reaction
during drug analysis. However, in this work, solvents played a key role in the decomposition of ARTS. The ARTS molecule degraded and formed several ARTs, including DHA,
ARTM and DHA dimers, at different rates in different solvent composition systems. In
methanol, ARTS mainly formed ARTM. The methyl group in methanol favors the formation
of ARTM from the degradation product of ARTS. The initial reactant peak decreased by
about 3.13%. When compared to ARTS, the percentage increases of DHA and ARTM were
16.16% and 68.69%, respectively. Meanwhile, ARTS in methanol and water mainly gave rise
to DHA and ARTM. The growths of DHA and ARTM were quite significant in the methanol
and water composition, where the initial reactant peak decreased by about 80%. When
compared to ARTS, the percentage increases of DHA, ARTM and DHA dimers were 97%,
100% and 15%, respectively. DHA increased by almost the same margin as the reduction of
ARTS. On the other hand, ARTS in methanol and ammonium acetate formed DHA, DHA
dimer and other reaction peaks. The main compound formed in this reaction was DHA.
The initial reactant peak decreased by about 97%. When compared to ARTS, the percentage
increases of DHA, ARTM, DHA dimers were 98.98%, 17.17% and 32.32%, respectively. It
is clear that the presence of water and ammonium acetate promoted the formation of the
DHA dimer. Other studies confirmed that the IC50 values of artemisinin-derived dimers in
cancer cells were significantly lower than those of monomeric ones [23,24].
The introduction of ammonium acetate in the solvent system resulted in the formation
of a colored compound at 37 ◦ C (Figure 5). The ARTS has a peroxide bond, whereas the
other molecule, ammonium acetate, acts as a nitrogen source. The mechanism behind this
reaction is speculated to be that the nitrogen from ammonia attacks ARTS and breaks the
peroxide bond, which enhances the conjugation reaction that results in the formation of
the colored compound. Figure S4 shows the mechanism of conjugation between ARTS
and nitrogen in 20 mM ammonium acetate/methanol at 37 ◦ C. The drug molecule ARTS’
color change occurred as a result of conjugation between the drug and ammonia in the
solvent at 37 ◦ C. Figure 5A–C show a comparison between the ARTS reaction in methanol,
methanol/water and 20 mM ammonium acetate/methanol solvents respectively. A and B
show a clear solution while B which was ARTS show an orange color.
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5. Conclusions
5. Conclusions
In this work, we have explored the decomposition of ARTS in different solvent systems,
In this work, we have explored the decomposition of ARTS in different solvent sysnamely in methanol, methanol with water, and methanol, water, and ammonium acetate.
tems, namely in methanol, methanol with water, and methanol, water, and ammonium
In all three solvent systems, ARTS decomposed at different rates into DHA, ARTM and
acetate. In all three solvent systems, ARTS decomposed at different rates into DHA,
DHA dimers, among major products. There were other products formed and not identified,
ARTM and DHA dimers, among major products. There were other products formed and
as their peak intensities were low. The presence of ammonium acetate in the solvent
not identified, as their peak intensities were low. The presence of ammonium acetate in
system resulted in the formation of a bright orange solution at five days, a confirmation of
the solvent system resulted in the formation of a bright orange solution at five days, a
conjugation from the breakdown of the endo-peroxide bond. These degradation reactions
were only observed when the mixture was incubated at 37 ◦ C. ARTS at 37 ◦ C in methanol
with water and ammonium acetate produced DHA at the highest rate compared to the other
solvent systems, while the methanol with water system produced ARTM at the highest
rate. The study of the ART derivatives at this temperature is key to understanding the drug
activity in vivo as well as to altering the methods that are used to analyze the derivatives.
Supplementary Materials: The following supporting information can be downloaded at:
https://www.mdpi.com/article/10.3390/separations9080218/s1, Figure S1: Mass spectrum of ARTS
reaction products in methanol at 0.9 min (A), 1.2 min (B), 1.6 min (C), 1.9 min (D), 2.1 min (E),
2.8 min (F), 3.1 min (G), 3.4 min (H) and 6.0 min (I). Figure S2: Mass spectrum of ARTS reaction products in methanol/water at 0.5 min (A), 1.0 min (B), 1.6 min (C), 1.9 min (D), 2.8 min (E),
3.2 min (F), 3.5 min (G) and 6.0 min (H). Figure S3: Mass spectrum of ARTS reaction products in
20 mM ammonium acetate: methanol at 0.5 min (A), 0.7 min (B), 0.8 min (C), 0.9 min (D), 1.2 min (E),
1.3 min (F), 1.9 min (G), 2.8 min (H) and 6.0 min (I). Figure S4: Mechanism of conjugation between
ARTS and nitrogen in 20 mM ammonium acetate/methanol at 37 ◦ C. Table S1: Identification of mass
fragments of artesunate reaction products in methanol. Table S2: Identification of mass fragments
of artesunate reaction products in methanol: water. Table S3: Identification of mass fragments of
artesunate reaction products in 20 mM Ammonium Acetate: methanol.
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